Waife & Associates, Inc. Adds Mark Di Ianni as Principal Consultant

NEEDHAM, Mass., June 21, 2011 /PRNewswire/ -- Waife & Associates, Inc. (W&A), change management consultants in clinical research, announced today that it is adding the consulting practice of Mark Di Ianni, MDI Consulting Services LLC, to its scope of services. Di Ianni has been a senior executive in the CRO (contract research organization) industry for three decades, founding and/or managing a series of successful companies. In recent years his consulting practice  has focused on helping CROs and other service vendors grow their businesses, and on investors seeking to capitalize that growth. Before MDI Consulting, Mark's most recent position was President of Early Stage Development and Executive Vice President of Strategic Initiatives at PharmaNet Development Group.

W&A has seen the development of a service provider management practice as a natural extension of its process improvement and technology Organizational Preparedness™ practices. Di Ianni's consulting practice has direct relevance to the research sponsor community that W&A has primarily served. Both parties see the synergy of this combination helping both sponsors and service providers improve the research process.

"I can't think of a stronger statement of commitment to our service provider management practice than adding Mark Di Ianni to manage this effort," said Ronald S. Waife, President of Waife & Associates, Inc.. "W&A's purpose is to speed access to new therapies by improving the process of clinical development. Improving service provider management by research sponsors is critical to ensure that the industry's choice for outsourcing is effective and efficient. Mark's long executive career in the service provider community is the perfect complement to W&A's management consulting and process improvement work." Ron added, "In addition, Mark's executive and strategy skills will inform all of W&A's consulting and increase the value for our clients."

"I have long respected the contributions of Waife & Associates and have worked with them in previous roles," said Mark. "The opportunity to join with them and expand the breadth of my contributions on a consulting basis is very exciting. W&A's approach to pragmatic innovation, and ensuring the efficiency of change, are critical concepts to clinical research today. I look forward to helping W&A grow its impact on the industry."

Mark will be working out of his office in the Princeton, NJ area. Mark can be reached at [email protected] or +1 (609) 381-0861. To learn more about Waife & Associates, Inc., visit www.waife.com.

SOURCE Waife & Associates, Inc.